CO2 laser laparoscopy in tubo-ovarian infertility

article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This paper investigates the efficacy of CO2 laser laparoscopy in treating tubo-ovarian infertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Since 1985, more than 500 CO2 laser laparoscopic procedures have been done, including treatment of endometriosis, adhesiolysis, salpingo-ovariolysis and salpingoneostomy. The most frequent indication was endometriosis. The results were as follows. Endometriosis: 85 patients total. In AFS Stage 1-2: 17/30 (57%) ongoing pregnancies; AFS Stage 3:18/37 (48%) ongoing pregnancies; and AFS Stage 4: 6/16 (38%) ongoing pregnancies. Adhesiolysis: Degree I, 76 patients with 51 (65%) ongoing pregnancies. Degree II, 84 patients with 41 (50%) pregnancies. Fimbrioplasty: 63 patients with 40 (64%) ongoing pregnancies, and 3 women developed ectopic pregnancies. Salpingoneostomy: 43 patients with 10 (20%) ongoing pregnancies and 2 women with ectopic pregnancies. These results are equivalent to microsurgical ones. For the last 150 operations, the new ultrapulse 500 L (Coherent) laser has been used and appeared to produce less tissue damage. No major complications. In conclusion, laparoscopic surgery with CO2 laser appears at least as effective as microsurgery for patients suffering from infertility.

My notes (saved in your browser only)

Condition tags

infertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-21T06:08:07.822426+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:24.284338+00:00
License: CC0 · commercial use OK